nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—PPARG—type 2 diabetes mellitus	0.133	0.417	CbGaD
Sulfasalazine—ABCC2—type 2 diabetes mellitus	0.13	0.407	CbGaD
Sulfasalazine—PPARG—Glipizide—type 2 diabetes mellitus	0.0777	0.156	CbGbCtD
Sulfasalazine—PPARG—Repaglinide—type 2 diabetes mellitus	0.0679	0.136	CbGbCtD
Sulfasalazine—PPARG—Pioglitazone—type 2 diabetes mellitus	0.0614	0.123	CbGbCtD
Sulfasalazine—PPARG—Rosiglitazone—type 2 diabetes mellitus	0.0567	0.114	CbGbCtD
Sulfasalazine—PTGS2—type 2 diabetes mellitus	0.0562	0.176	CbGaD
Sulfasalazine—PPARG—Nateglinide—type 2 diabetes mellitus	0.0466	0.0933	CbGbCtD
Sulfasalazine—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0233	0.0468	CbGbCtD
Sulfasalazine—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0211	0.0423	CbGbCtD
Sulfasalazine—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0195	0.039	CbGbCtD
Sulfasalazine—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0172	0.0345	CbGbCtD
Sulfasalazine—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0155	0.031	CbGbCtD
Sulfasalazine—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0155	0.031	CbGbCtD
Sulfasalazine—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0143	0.0286	CbGbCtD
Sulfasalazine—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0117	0.0235	CbGbCtD
Sulfasalazine—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0112	0.0225	CbGbCtD
Sulfasalazine—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00989	0.0198	CbGbCtD
Sulfasalazine—ABCC2—Glyburide—type 2 diabetes mellitus	0.0095	0.019	CbGbCtD
Sulfasalazine—ABCG2—Glyburide—type 2 diabetes mellitus	0.00859	0.0172	CbGbCtD
Sulfasalazine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00704	0.0141	CbGbCtD
Sulfasalazine—ACAT1—brown adipose tissue—type 2 diabetes mellitus	0.00673	0.109	CbGeAlD
Sulfasalazine—SLC7A11—forelimb zeugopod—type 2 diabetes mellitus	0.00656	0.106	CbGeAlD
Sulfasalazine—TBXAS1—leg—type 2 diabetes mellitus	0.00453	0.0734	CbGeAlD
Sulfasalazine—CYP3A5—Losartan—type 2 diabetes mellitus	0.00435	0.00872	CbGbCtD
Sulfasalazine—TBXAS1—hindlimb—type 2 diabetes mellitus	0.00404	0.0656	CbGeAlD
Sulfasalazine—PPARG—brown adipose tissue—type 2 diabetes mellitus	0.00212	0.0344	CbGeAlD
Sulfasalazine—PPARG—leg—type 2 diabetes mellitus	0.00171	0.0277	CbGeAlD
Sulfasalazine—PPARG—hindlimb—type 2 diabetes mellitus	0.00152	0.0247	CbGeAlD
Sulfasalazine—ACAT1—islet of Langerhans—type 2 diabetes mellitus	0.00142	0.0231	CbGeAlD
Sulfasalazine—ACAT1—nephron tubule—type 2 diabetes mellitus	0.00115	0.0186	CbGeAlD
Sulfasalazine—ACAT1—cardiovascular system—type 2 diabetes mellitus	0.00103	0.0167	CbGeAlD
Sulfasalazine—ACAT1—kidney—type 2 diabetes mellitus	0.00101	0.0164	CbGeAlD
Sulfasalazine—ACAT1—pancreas—type 2 diabetes mellitus	0.001	0.0162	CbGeAlD
Sulfasalazine—PLA2G1B—islet of Langerhans—type 2 diabetes mellitus	0.000998	0.0162	CbGeAlD
Sulfasalazine—ACAT1—cortex of kidney—type 2 diabetes mellitus	0.000982	0.0159	CbGeAlD
Sulfasalazine—PPARG—artery—type 2 diabetes mellitus	0.000934	0.0152	CbGeAlD
Sulfasalazine—ACAT1—adipose tissue—type 2 diabetes mellitus	0.000909	0.0147	CbGeAlD
Sulfasalazine—SLC7A11—islet of Langerhans—type 2 diabetes mellitus	0.000874	0.0142	CbGeAlD
Sulfasalazine—PTGS2—leg—type 2 diabetes mellitus	0.000872	0.0141	CbGeAlD
Sulfasalazine—TBXAS1—cardiovascular system—type 2 diabetes mellitus	0.000861	0.014	CbGeAlD
Sulfasalazine—PPARG—endothelium—type 2 diabetes mellitus	0.000789	0.0128	CbGeAlD
Sulfasalazine—PTGS2—hindlimb—type 2 diabetes mellitus	0.000779	0.0126	CbGeAlD
Sulfasalazine—CHUK—cardiovascular system—type 2 diabetes mellitus	0.000768	0.0125	CbGeAlD
Sulfasalazine—TBXAS1—adipose tissue—type 2 diabetes mellitus	0.000759	0.0123	CbGeAlD
Sulfasalazine—PLA2G1B—cardiovascular system—type 2 diabetes mellitus	0.000722	0.0117	CbGeAlD
Sulfasalazine—PLA2G1B—kidney—type 2 diabetes mellitus	0.000706	0.0115	CbGeAlD
Sulfasalazine—PLA2G1B—pancreas—type 2 diabetes mellitus	0.000702	0.0114	CbGeAlD
Sulfasalazine—CHUK—adipose tissue—type 2 diabetes mellitus	0.000677	0.011	CbGeAlD
Sulfasalazine—ACAT1—liver—type 2 diabetes mellitus	0.000637	0.0103	CbGeAlD
Sulfasalazine—SLC7A11—kidney—type 2 diabetes mellitus	0.000619	0.01	CbGeAlD
Sulfasalazine—SLC7A11—pancreas—type 2 diabetes mellitus	0.000614	0.00997	CbGeAlD
Sulfasalazine—ALOX5—islet of Langerhans—type 2 diabetes mellitus	0.000598	0.0097	CbGeAlD
Sulfasalazine—Balsalazide—PPARG—type 2 diabetes mellitus	0.000564	0.254	CrCbGaD
Sulfasalazine—SLC7A11—adipose tissue—type 2 diabetes mellitus	0.000557	0.00904	CbGeAlD
Sulfasalazine—TBXAS1—liver—type 2 diabetes mellitus	0.000533	0.00864	CbGeAlD
Sulfasalazine—IKBKB—cardiovascular system—type 2 diabetes mellitus	0.000522	0.00846	CbGeAlD
Sulfasalazine—PTGS1—artery—type 2 diabetes mellitus	0.0005	0.0081	CbGeAlD
Sulfasalazine—IKBKB—cortex of kidney—type 2 diabetes mellitus	0.000497	0.00807	CbGeAlD
Sulfasalazine—Olsalazine—PPARG—type 2 diabetes mellitus	0.00048	0.216	CrCbGaD
Sulfasalazine—PTGS2—artery—type 2 diabetes mellitus	0.000477	0.00775	CbGeAlD
Sulfasalazine—SLC46A1—liver—type 2 diabetes mellitus	0.000475	0.0077	CbGeAlD
Sulfasalazine—CHUK—liver—type 2 diabetes mellitus	0.000475	0.0077	CbGeAlD
Sulfasalazine—IKBKB—adipose tissue—type 2 diabetes mellitus	0.00046	0.00746	CbGeAlD
Sulfasalazine—PPARG—islet of Langerhans—type 2 diabetes mellitus	0.000449	0.00728	CbGeAlD
Sulfasalazine—ALOX5—cardiovascular system—type 2 diabetes mellitus	0.000432	0.00702	CbGeAlD
Sulfasalazine—PTGS1—endothelium—type 2 diabetes mellitus	0.000422	0.00684	CbGeAlD
Sulfasalazine—ALOX5—pancreas—type 2 diabetes mellitus	0.00042	0.00682	CbGeAlD
Sulfasalazine—PTGS2—endothelium—type 2 diabetes mellitus	0.000403	0.00654	CbGeAlD
Sulfasalazine—ALOX5—adipose tissue—type 2 diabetes mellitus	0.000381	0.00619	CbGeAlD
Sulfasalazine—SLCO1B1—kidney—type 2 diabetes mellitus	0.000368	0.00598	CbGeAlD
Sulfasalazine—PPARG—cardiovascular system—type 2 diabetes mellitus	0.000325	0.00527	CbGeAlD
Sulfasalazine—IKBKB—liver—type 2 diabetes mellitus	0.000323	0.00523	CbGeAlD
Sulfasalazine—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000318	0.00515	CbGeAlD
Sulfasalazine—PPARG—kidney—type 2 diabetes mellitus	0.000318	0.00515	CbGeAlD
Sulfasalazine—PPARG—pancreas—type 2 diabetes mellitus	0.000316	0.00512	CbGeAlD
Sulfasalazine—PPARG—adipose tissue—type 2 diabetes mellitus	0.000286	0.00464	CbGeAlD
Sulfasalazine—ABCC2—kidney—type 2 diabetes mellitus	0.000279	0.00453	CbGeAlD
Sulfasalazine—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000272	0.00441	CbGeAlD
Sulfasalazine—ALOX5—liver—type 2 diabetes mellitus	0.000267	0.00434	CbGeAlD
Sulfasalazine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000267	0.00433	CbGeAlD
Sulfasalazine—Sulfadiazine—CYP2E1—type 2 diabetes mellitus	0.000244	0.11	CrCbGaD
Sulfasalazine—Balsalazide—PTGS2—type 2 diabetes mellitus	0.000238	0.107	CrCbGaD
Sulfasalazine—SLCO1B1—liver—type 2 diabetes mellitus	0.000233	0.00378	CbGeAlD
Sulfasalazine—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000232	0.00376	CbGeAlD
Sulfasalazine—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000229	0.00372	CbGeAlD
Sulfasalazine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000215	0.00349	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—type 2 diabetes mellitus	0.000202	0.0912	CrCbGaD
Sulfasalazine—PPARG—liver—type 2 diabetes mellitus	0.000201	0.00326	CbGeAlD
Sulfasalazine—CYP3A5—kidney—type 2 diabetes mellitus	0.000189	0.00307	CbGeAlD
Sulfasalazine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000188	0.00305	CbGeAlD
Sulfasalazine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000184	0.00299	CbGeAlD
Sulfasalazine—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000184	0.00298	CbGeAlD
Sulfasalazine—Vismodegib—CYP3A4—type 2 diabetes mellitus	0.000181	0.0817	CrCbGaD
Sulfasalazine—ABCC2—liver—type 2 diabetes mellitus	0.000177	0.00286	CbGeAlD
Sulfasalazine—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000174	0.00282	CbGeAlD
Sulfasalazine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.00017	0.00276	CbGeAlD
Sulfasalazine—PTGS1—kidney—type 2 diabetes mellitus	0.00017	0.00276	CbGeAlD
Sulfasalazine—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000166	0.00269	CbGeAlD
Sulfasalazine—PTGS2—kidney—type 2 diabetes mellitus	0.000162	0.00263	CbGeAlD
Sulfasalazine—PTGS2—pancreas—type 2 diabetes mellitus	0.000161	0.00262	CbGeAlD
Sulfasalazine—Vismodegib—ALB—type 2 diabetes mellitus	0.000158	0.0712	CrCbGaD
Sulfasalazine—Sulfadiazine—CYP3A4—type 2 diabetes mellitus	0.000153	0.0691	CrCbGaD
Sulfasalazine—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000153	0.00248	CbGeAlD
Sulfasalazine—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000146	0.00237	CbGeAlD
Sulfasalazine—ABCG2—liver—type 2 diabetes mellitus	0.000129	0.00209	CbGeAlD
Sulfasalazine—CYP3A5—liver—type 2 diabetes mellitus	0.000119	0.00194	CbGeAlD
Sulfasalazine—PTGS2—liver—type 2 diabetes mellitus	0.000103	0.00166	CbGeAlD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.65e-06	2.26e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOB—type 2 diabetes mellitus	2.65e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PIK3R1—type 2 diabetes mellitus	2.65e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT2—type 2 diabetes mellitus	2.64e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	2.62e-06	2.23e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	2.62e-06	2.22e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	2.6e-06	2.21e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.59e-06	2.21e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	2.59e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOB—type 2 diabetes mellitus	2.59e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSTM1—type 2 diabetes mellitus	2.58e-06	2.19e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.58e-06	2.19e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.57e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	2.57e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—EGFR—type 2 diabetes mellitus	2.56e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.56e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SERPINE1—type 2 diabetes mellitus	2.56e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.56e-06	2.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	2.55e-06	2.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—BCL2—type 2 diabetes mellitus	2.55e-06	2.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	2.55e-06	2.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.55e-06	2.17e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	2.54e-06	2.16e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—LPL—type 2 diabetes mellitus	2.53e-06	2.15e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—type 2 diabetes mellitus	2.52e-06	2.14e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.51e-06	2.13e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.5e-06	2.13e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—RELA—type 2 diabetes mellitus	2.49e-06	2.12e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—INS—type 2 diabetes mellitus	2.49e-06	2.11e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ADCY5—type 2 diabetes mellitus	2.48e-06	2.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	2.48e-06	2.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	2.48e-06	2.1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LPL—type 2 diabetes mellitus	2.47e-06	2.1e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GPX1—type 2 diabetes mellitus	2.47e-06	2.1e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	2.46e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	2.46e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.46e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—C3—type 2 diabetes mellitus	2.45e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PIK3R1—type 2 diabetes mellitus	2.44e-06	2.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS3—type 2 diabetes mellitus	2.44e-06	2.08e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	2.44e-06	2.07e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	2.43e-06	2.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.42e-06	2.06e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	2.41e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOB—type 2 diabetes mellitus	2.41e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	2.41e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	2.41e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CD36—type 2 diabetes mellitus	2.4e-06	2.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PIK3R1—type 2 diabetes mellitus	2.4e-06	2.04e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	2.38e-06	2.02e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.37e-06	2.02e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	2.37e-06	2.02e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	2.35e-06	2e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.34e-06	1.99e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	2.34e-06	1.99e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.33e-06	1.98e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AGT—type 2 diabetes mellitus	2.33e-06	1.98e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.32e-06	1.97e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	2.31e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	2.31e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—BCL2—type 2 diabetes mellitus	2.31e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	2.31e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—LPL—type 2 diabetes mellitus	2.3e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	2.3e-06	1.95e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.29e-06	1.95e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	2.29e-06	1.95e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOE—type 2 diabetes mellitus	2.28e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—LEP—type 2 diabetes mellitus	2.28e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—type 2 diabetes mellitus	2.28e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.28e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ALB—type 2 diabetes mellitus	2.28e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	2.28e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.28e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	2.26e-06	1.93e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—type 2 diabetes mellitus	2.26e-06	1.93e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—RELA—type 2 diabetes mellitus	2.26e-06	1.92e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.26e-06	1.92e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	2.26e-06	1.92e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	2.24e-06	1.9e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—type 2 diabetes mellitus	2.23e-06	1.9e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—C3—type 2 diabetes mellitus	2.22e-06	1.89e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	2.19e-06	1.86e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-06	1.85e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-06	1.85e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	2.16e-06	1.84e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	2.16e-06	1.84e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.15e-06	1.83e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	2.15e-06	1.83e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	2.13e-06	1.81e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CCR5—type 2 diabetes mellitus	2.12e-06	1.81e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.12e-06	1.8e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	2.12e-06	1.8e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.12e-06	1.8e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	2.12e-06	1.8e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.12e-06	1.8e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AGT—type 2 diabetes mellitus	2.11e-06	1.8e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	2.11e-06	1.79e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NFKB1—type 2 diabetes mellitus	2.1e-06	1.79e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	2.1e-06	1.78e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—type 2 diabetes mellitus	2.09e-06	1.78e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	2.08e-06	1.77e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	2.08e-06	1.77e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.08e-06	1.77e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	2.07e-06	1.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LEP—type 2 diabetes mellitus	2.07e-06	1.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOE—type 2 diabetes mellitus	2.07e-06	1.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—type 2 diabetes mellitus	2.05e-06	1.75e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.05e-06	1.74e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	2.04e-06	1.74e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	2.04e-06	1.73e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.04e-06	1.73e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	2.02e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	2.01e-06	1.71e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—type 2 diabetes mellitus	2.01e-06	1.71e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	2e-06	1.7e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	1.7e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.99e-06	1.69e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	1.99e-06	1.69e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	1.98e-06	1.69e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	1.98e-06	1.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IRS2—type 2 diabetes mellitus	1.97e-06	1.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	1.97e-06	1.67e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—SRC—type 2 diabetes mellitus	1.96e-06	1.66e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	1.96e-06	1.66e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	1.96e-06	1.66e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.95e-06	1.66e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—INS—type 2 diabetes mellitus	1.95e-06	1.66e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CALM1—type 2 diabetes mellitus	1.94e-06	1.65e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOE—type 2 diabetes mellitus	1.93e-06	1.64e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	1.93e-06	1.64e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.92e-06	1.63e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOA1—type 2 diabetes mellitus	1.91e-06	1.62e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NFKB1—type 2 diabetes mellitus	1.9e-06	1.62e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	1.9e-06	1.61e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—type 2 diabetes mellitus	1.89e-06	1.61e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	1.89e-06	1.61e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.89e-06	1.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.89e-06	1.6e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	1.88e-06	1.6e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	1.85e-06	1.57e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.85e-06	1.57e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	1.85e-06	1.57e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	1.83e-06	1.56e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.82e-06	1.55e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	1.81e-06	1.54e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—INS—type 2 diabetes mellitus	1.81e-06	1.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.81e-06	1.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SRC—type 2 diabetes mellitus	1.81e-06	1.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS2—type 2 diabetes mellitus	1.8e-06	1.53e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	1.79e-06	1.53e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.79e-06	1.52e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	1.77e-06	1.51e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	1.77e-06	1.51e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—SRC—type 2 diabetes mellitus	1.77e-06	1.51e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—INS—type 2 diabetes mellitus	1.77e-06	1.5e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	1.77e-06	1.5e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—INS—type 2 diabetes mellitus	1.74e-06	1.48e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.74e-06	1.48e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	1.74e-06	1.48e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IRS1—type 2 diabetes mellitus	1.72e-06	1.47e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	1.72e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.72e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.72e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EGFR—type 2 diabetes mellitus	1.72e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.71e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.71e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.71e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.71e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	1.7e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	1.7e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	1.66e-06	1.41e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	1.65e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—INS—type 2 diabetes mellitus	1.65e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	1.63e-06	1.39e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.62e-06	1.38e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	1.62e-06	1.38e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—type 2 diabetes mellitus	1.62e-06	1.38e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	1.62e-06	1.38e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—type 2 diabetes mellitus	1.62e-06	1.37e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RELA—type 2 diabetes mellitus	1.61e-06	1.37e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	1.6e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	1.6e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	1.6e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT2—type 2 diabetes mellitus	1.59e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.59e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	1.59e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EGFR—type 2 diabetes mellitus	1.58e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.57e-06	1.33e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EGFR—type 2 diabetes mellitus	1.56e-06	1.32e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.55e-06	1.32e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.55e-06	1.32e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	1.55e-06	1.32e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	1.53e-06	1.3e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.53e-06	1.3e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	1.53e-06	1.3e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	1.52e-06	1.29e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	1.52e-06	1.29e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	1.5e-06	1.28e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RELA—type 2 diabetes mellitus	1.46e-06	1.24e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	1.45e-06	1.24e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.45e-06	1.24e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—type 2 diabetes mellitus	1.45e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	1.41e-06	1.2e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	1.4e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—INS—type 2 diabetes mellitus	1.38e-06	1.18e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.37e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.36e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	1.32e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—type 2 diabetes mellitus	1.32e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.32e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.3e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—type 2 diabetes mellitus	1.29e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	1.27e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SRC—type 2 diabetes mellitus	1.27e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.23e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—type 2 diabetes mellitus	1.22e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—type 2 diabetes mellitus	1.22e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.21e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	1.21e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—type 2 diabetes mellitus	1.2e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.19e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SRC—type 2 diabetes mellitus	1.15e-06	9.76e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.14e-06	9.68e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.14e-06	9.68e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.13e-06	9.62e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—type 2 diabetes mellitus	1.12e-06	9.55e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.12e-06	9.5e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.11e-06	9.43e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—type 2 diabetes mellitus	1.1e-06	9.38e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SRC—type 2 diabetes mellitus	1.07e-06	9.1e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.04e-06	8.86e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-06	8.72e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-06	8.55e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	8.52e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	9.57e-07	8.14e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGFR—type 2 diabetes mellitus	9.38e-07	7.98e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—type 2 diabetes mellitus	8.52e-07	7.25e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	7.89e-07	6.71e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.86e-07	6.69e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—type 2 diabetes mellitus	7.73e-07	6.57e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	7.3e-07	6.21e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—type 2 diabetes mellitus	7.21e-07	6.13e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.13e-07	6.06e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	7.02e-07	5.97e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—type 2 diabetes mellitus	6.65e-07	5.66e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	5.57e-07	4.74e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	5.23e-07	4.45e-06	CbGpPWpGaD
